HFA Premium Access

Impact of Iron Deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.

Congress Presentation

About the speaker

Doctor Pieter Martens

Hospital Oost-Limburg (ZOL), Genk (Belgium)
3 presentations
1 follower

9 more presentations in this session

Phase 2 open-label extension (OLE) study of patisiran for the treatment of hereditary ATTR (hATTR) amyloidosis: 24-month safety and efficacy in subgroup of patients with cardiac involvement

Speaker: Professor D. Adams (Le Kremlin-Bicetre Cedex, FR)

Thumbnail

Heart failure and inflammation-related biomarkers as predictors of new onset diabetes in the general population

Speaker: Doctor N. Suthahar (Rotterdam, NL)

Thumbnail

Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- versus post-capillary pulmonary hypertension.

Speaker: Mr T. Gorter (Groningen, NL)

Thumbnail

Definition of iron deficiency based on the gold standard of bone marrow iron staining and treatment effect of ferric carboxymaltose in heart failure patients

Speaker: Mr N. Grote Beverborg (Groningen, NL)

Thumbnail

Circulating miRNAs as biomarkers for familial dilated cardiomyopathy

Speaker: Doctor D. De Gonzalo Calvo (Barcelona, ES)

Thumbnail

Access the full session

Rapid Fire 2 - Comorbodities

Speakers: Doctor P. Martens, Professor D. Adams, Doctor N. Suthahar, Mr T. Gorter, Mr N. Grote Beverborg...
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations